Nektar Therapeutics: Balancing The Immune System To Potential Blockbuster Markets
Nektar Therapeutics develops novel immunomodulatory drugs targeting autoimmune diseases and oncology, leveraging its expertise in immune system regulation.Recent Phase 2 results for Atopic Dermatitis met endpoints, validating NKTR's approach and
admin